CA2319782A1 - Retinoblastoma protein complexes and retinoblastoma interacting proteins - Google Patents
Retinoblastoma protein complexes and retinoblastoma interacting proteins Download PDFInfo
- Publication number
- CA2319782A1 CA2319782A1 CA002319782A CA2319782A CA2319782A1 CA 2319782 A1 CA2319782 A1 CA 2319782A1 CA 002319782 A CA002319782 A CA 002319782A CA 2319782 A CA2319782 A CA 2319782A CA 2319782 A1 CA2319782 A1 CA 2319782A1
- Authority
- CA
- Canada
- Prior art keywords
- protein
- complex
- derivative
- glut1
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4736—Retinoblastoma protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7455998P | 1998-02-12 | 1998-02-12 | |
| US60/074,559 | 1998-02-12 | ||
| US24896099A | 1999-02-11 | 1999-02-11 | |
| US09/248,960 | 1999-02-11 | ||
| PCT/US1999/003072 WO1999041376A2 (en) | 1998-02-12 | 1999-02-12 | Retinoblastoma protein complexes and retinoblastoma interacting proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2319782A1 true CA2319782A1 (en) | 1999-08-19 |
Family
ID=26755794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002319782A Abandoned CA2319782A1 (en) | 1998-02-12 | 1999-02-12 | Retinoblastoma protein complexes and retinoblastoma interacting proteins |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1054969A2 (de) |
| JP (1) | JP2002503466A (de) |
| CA (1) | CA2319782A1 (de) |
| WO (1) | WO1999041376A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6476193B1 (en) * | 1998-10-06 | 2002-11-05 | Curagen Corporation | NLK1 protein and NLK1 protein complexes |
| WO2004014301A2 (en) * | 2002-08-07 | 2004-02-19 | Exelixis, Inc. | PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE |
| AU2003294499A1 (en) * | 2002-11-25 | 2004-06-18 | Exelixis, Inc. | Rhebs as modifiers of the rb pathway and methods of use |
| US7994306B2 (en) | 2006-11-13 | 2011-08-09 | The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center | Methods of treating cancer using siRNA molecules directed against CD24 |
| US20240335147A1 (en) * | 2023-04-05 | 2024-10-10 | Medtronic Minimed, Inc. | Analyte transporting membranes for use with analyte sensors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6071715A (en) * | 1993-08-12 | 2000-06-06 | Board Of Regents, The University Of Texas System | Nucleic acids encoding novel proteins which bind to retinoblastoma protein |
| EP0685493A1 (de) * | 1994-06-01 | 1995-12-06 | CANJI, Inc. | Tumorsuppressor-Fusionsproteine |
| WO1998021228A1 (en) * | 1996-11-15 | 1998-05-22 | Canji, Inc. | Tissue specific expression of retinoblastoma protein |
-
1999
- 1999-02-10 EP EP99932509A patent/EP1054969A2/de not_active Withdrawn
- 1999-02-12 WO PCT/US1999/003072 patent/WO1999041376A2/en not_active Ceased
- 1999-02-12 JP JP2000531557A patent/JP2002503466A/ja not_active Withdrawn
- 1999-02-12 CA CA002319782A patent/CA2319782A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999041376A9 (en) | 2001-02-01 |
| JP2002503466A (ja) | 2002-02-05 |
| EP1054969A2 (de) | 2000-11-29 |
| WO1999041376A2 (en) | 1999-08-19 |
| WO1999041376A3 (en) | 2000-02-10 |
| WO1999041376A8 (en) | 2000-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6627405B1 (en) | 53BP2 complexes | |
| AU4869399A (en) | Interaction of human beta amyloid precursor protein (beta-app) with human lon-protease like protein (hslon) | |
| JP2002510490A (ja) | Lystタンパク質複合体およびlyst相互作用タンパク質 | |
| AU778692B2 (en) | NLK1 -interacting proteins | |
| AU761651B2 (en) | CDK2 protein and CDK2 protein complexes | |
| EP1177286A1 (de) | Mdm interagierendes protein und methode für seine verwendungen | |
| AU770000B2 (en) | Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof | |
| CA2319782A1 (en) | Retinoblastoma protein complexes and retinoblastoma interacting proteins | |
| AU4690499A (en) | Interaction of p27(kip1) with fkbp-12 | |
| AU3291799A (en) | Retinoblastoma protein complexes and retinoblastoma interacting proteins | |
| CA2349839C (en) | Ucp5 | |
| WO2002102987A2 (en) | Methods and compositions based on protein interactions with mastermind |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |